Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH

NARecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

January 3, 2026

Study Completion Date

September 1, 2026

Conditions
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Interventions
DEVICE

Omega device

"The ProArc Medical Omega system is a prostatic reshaping device. The Omega System is comprised of two main components: Omega Delivery Device and Omega Implant.~The delivery system uses a diathermy electrode to perform a circular and superficial incision through the urethral wall into the prostate tissue, into which the arc-shaped permanent implant is placed. The implant is made up of commonly used surgical implantable nitinol material, coated with Parylene coating. The implant expands the obstructed area, reducing the fluid obstruction through the prostatic urethra."

Trial Locations (5)

0159

RECRUITING

N(N)LE New Vision University Hospital, Tbilisi

Unknown

RECRUITING

Israeli-Georgian Medical Research Clinic Healthycore, Tbilisi

RECRUITING

JSC L.Managadze National Center of Urology, Tbilisi

RECRUITING

Tbilisi Heart Center, Tbilisi

TERMINATED

Todua Clinic, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ProArc Medical

INDUSTRY

NCT05757687 - Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH | Biotech Hunter | Biotech Hunter